{"id":1161,"date":"2023-04-13T09:01:26","date_gmt":"2023-04-13T09:01:26","guid":{"rendered":"https:\/\/www.hemmi-stiftung.ch\/?page_id=1161"},"modified":"2026-03-19T16:31:20","modified_gmt":"2026-03-19T16:31:20","slug":"hemmi-prize","status":"publish","type":"page","link":"https:\/\/www.hemmi-stiftung.ch\/en\/hemmi-prize\/","title":{"rendered":"HEMMI Prize"},"content":{"rendered":"

<\/div>
<\/div><\/div><\/span>

HEMMI – Prize<\/h1><\/span>
<\/div><\/div><\/div>
<\/div><\/div>

This research prize is awarded twice a year and we encourage younger researchers in particular to submit their projects.<\/p>\n<\/div>

<\/div>\n<\/div><\/div><\/div><\/div>
<\/div><\/div><\/span>

Research Prize 2026 of the <\/span> \u201eHemmi\u201c Foundation<\/h2><\/span>
<\/div><\/div><\/div>
<\/div><\/div>

The “Hemmi Foundation” for the promotion of clinical research<\/p>\n

donates in the year 2026<\/p>\n

two prizes of 25,000 Swiss francs each.<\/strong><\/p>\n

The call for applications is addressed to young researchers working on a project in the field of medical research in general or in oncology in particular at a Swiss clinic, institute or in private practice. The application should include a description of the project, the study protocol approved by the ethics committee, any results and publications already available, information on the intended purpose and a curriculum vitae.<\/p>\n

Candidates are requested to send their application digitally in PDF format, to lic. iur. Simon Rosenthaler, President of the Board of the Hemmi Foundation, rosenthaler@ar-law.ch<\/a>, by 30 June 2026. We kindly ask you to submit your application in one single PDF file.<\/p>\n<\/div><\/div><\/div><\/div><\/div>

<\/div><\/div><\/span>

The prize winners<\/span> from 2025<\/h3><\/h3><\/span>
<\/div><\/div><\/div>
<\/div><\/div><\/div><\/div>
\"Salome<\/span><\/div><\/div><\/div>

Dr. phil. Salome Hosch PHD
<\/strong>(together with Dr. Baptiste Hamelin)<\/strong><\/p>\n

Project title:
\n<\/span>Molecular tissue-based precision diagnostics of infectious diseases<\/p>\n

University Hospital Basel, Institute of Medical Genetics and Pathology, 4031 Basel<\/p>\n<\/div><\/div><\/div>

\"Baptiste<\/span><\/div><\/div><\/div>

Dr. Baptiste Hamelin PHD
<\/strong>(together with Dr. Salome Hosch)<\/strong><\/p>\n

Project title:
\n<\/span>Molecular tissue-based precision diagnostics of infectious diseases<\/p>\n

University Hospital Basel, Institute of Medical Genetics and Pathology, 4031 Basel<\/p>\n<\/div><\/div><\/div>

\"Tibor<\/span><\/div><\/div><\/div>

Dr. med. Tibor Andrea Zwimpfer<\/strong><\/p>\n

Project title:
\n<\/span>RB1 loss and depth of homologous recombination deficiency as predictors
\nof outcomes with olaparib and bevacizumab in first-line maintenance of ovarian cancer: a PAOLA-1 substudy<\/p>\n

University Hospital Basel, Department of Gynaecology and Obstetrics, 4031 Basel<\/p>\n<\/div><\/div><\/div><\/div><\/div>

<\/div><\/div><\/span>

The prize winners<\/span> from 2024<\/h3><\/h3><\/span>
<\/div><\/div><\/div>
<\/div><\/div><\/div><\/div>
\"Dr.med.<\/span><\/div><\/div><\/div>

Dr.med. Franziska Geissler<\/strong><\/p>\n

Project title:
\n<\/span>Silencing PARP inhibitor resistance – Exploiting BRCA1 and RAD51C methylation stability to improve PARP inhibitor responses in high-grade serous ovarian carcinomas<\/p>\n

University Hospital Basel, Department of Gynecology and Obstetrics, 4031 Basel<\/p>\n<\/div><\/div><\/div>

\"Prof.<\/span><\/div><\/div><\/div>

Prof. Dr. med. Katharina Timper <\/strong><\/p>\n

Project title:
\n<\/span>Odour-based volatile small molecules for metabolism control \u2013 The OLFAMED project<\/span><\/p>\n

University Hospital Basel, Department of Endocrinology, Diabetology and Metabolism, 4031 Basel<\/p>\n<\/div><\/div><\/div><\/div><\/div>

<\/div><\/div><\/span>

The prize winners<\/span> from 2023<\/h3><\/h3><\/span>
<\/div><\/div><\/div>
<\/div><\/div><\/div><\/div>
\"Dr<\/span><\/div><\/div><\/div>

Eliane Rohner MD MSc<\/strong><\/p>\n

Project title:
\n<\/span>DNA methylation tests for the detection of persistent precancerous cervical lesions in women living with HIV in Zimbabwe<\/p>\n

Institute of Social and Preventive Medicine
\nUniversity of Bern, 3012 Bern<\/span><\/p>\n<\/div><\/div><\/div>

\"Dr.<\/span><\/div><\/div><\/div>

Cihan Atila Dr. med.<\/strong><\/p>\n

Project title:
\n<\/span>Oxytocin Substitution therapy in patients with central diabetes insipidus: a double-blind randomized-controlled trial<\/span><\/p>\n

Department of Endocrinology, Diabetology and Metabolism University Hospital Basel, 4031 Basel<\/p>\n<\/div><\/div><\/div><\/div><\/div>

<\/div><\/div><\/span>

The prize winners<\/span> from 2022<\/h3><\/h3><\/span>
<\/div><\/div><\/div>
<\/div><\/div><\/div><\/div>
\"Christine<\/span><\/div><\/div><\/div>

Christine Schneider MD
\n<\/strong>Paediatric Oncologist, PhD student
\n<\/strong><\/p>\n

Project title:
\nEarly pulmonary dysfunction in paediatric cancer patients
\n(SWISS-Pearl Study)<\/p>\n

Paediatric Haematology and Oncology, Department of Paediatrics, Inselspital, Bern University Hospital and Department of Paediatric Pulmonology, UKBB Basel<\/p>\n<\/div><\/div><\/div>

\"Charly<\/span><\/div><\/div><\/div>

Charly Jehanno MD
\n<\/strong>Postdoctoral researcher in Molecular biology and Cancerology
\n<\/strong><\/p>\n

Project title:
\nNNMT evokes epigenetic rewiring and promotes metastatic colonization in breast cancer<\/p>\n

University of Basel, Department of Biomedcine Laboratory: Tumor Heterogeneity, Metastasis und Resistance (THMR); Lab Head: Prof. Mohamed Bentires-Alj<\/p>\n<\/div><\/div><\/div><\/div><\/div>

<\/div>
<\/div><\/div><\/p>\n","protected":false},"excerpt":{"rendered":"","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"100-width.php","meta":{"footnotes":""},"class_list":["post-1161","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/www.hemmi-stiftung.ch\/en\/wp-json\/wp\/v2\/pages\/1161","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.hemmi-stiftung.ch\/en\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.hemmi-stiftung.ch\/en\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.hemmi-stiftung.ch\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.hemmi-stiftung.ch\/en\/wp-json\/wp\/v2\/comments?post=1161"}],"version-history":[{"count":42,"href":"https:\/\/www.hemmi-stiftung.ch\/en\/wp-json\/wp\/v2\/pages\/1161\/revisions"}],"predecessor-version":[{"id":1469,"href":"https:\/\/www.hemmi-stiftung.ch\/en\/wp-json\/wp\/v2\/pages\/1161\/revisions\/1469"}],"wp:attachment":[{"href":"https:\/\/www.hemmi-stiftung.ch\/en\/wp-json\/wp\/v2\/media?parent=1161"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}